NCM
Nantahala Capital Management’s Lyra Therapeutics LYRA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-2,820,982
| Closed | -$17.5M | – | 130 |
|
|
2024
Q1 | $17.5M | Sell |
2,820,982
-1,229,236
| -30% | -$7.65M | 1% | 13 |
|
|
2023
Q4 | $21.2M | Hold |
4,050,218
| – | – | 1.27% | 11 |
|
|
2023
Q3 | $15.8M | Buy |
4,050,218
+92,676
| +2% | +$362K | 1.35% | 12 |
|
|
2023
Q2 | $16.3M | Buy |
3,957,542
+1,736,712
| +78% | +$7.14M | 1.57% | 11 |
|
|
2023
Q1 | $4.46M | Hold |
2,220,830
| – | – | 0.34% | 44 |
|
|
2022
Q4 | $6.97M | Sell |
2,220,830
-25,000
| -1% | -$78.5K | 0.45% | 37 |
|
|
2022
Q3 | $11.3M | Sell |
2,245,830
-123,838
| -5% | -$620K | 0.73% | 28 |
|
|
2022
Q2 | $13.4M | Buy |
+2,369,668
| New | +$13.4M | 0.67% | 27 |
|